Xuebiao Wei

1.1k total citations
79 papers, 645 citations indexed

About

Xuebiao Wei is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Xuebiao Wei has authored 79 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cardiology and Cardiovascular Medicine, 30 papers in Epidemiology and 22 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Xuebiao Wei's work include Infective Endocarditis Diagnosis and Management (20 papers), Streptococcal Infections and Treatments (19 papers) and Cardiac Valve Diseases and Treatments (15 papers). Xuebiao Wei is often cited by papers focused on Infective Endocarditis Diagnosis and Management (20 papers), Streptococcal Infections and Treatments (19 papers) and Cardiac Valve Diseases and Treatments (15 papers). Xuebiao Wei collaborates with scholars based in China, United States and Hong Kong. Xuebiao Wei's co-authors include Danqing Yu, Pengcheng He, Ji-yan Chen, Liu Y, Ning Tan, Lei Jiang, Tiehe Qin, Zhonghua Wang, Jianfeng Cao and Yanbin Fu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Scientific Reports.

In The Last Decade

Xuebiao Wei

71 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuebiao Wei China 15 197 157 120 93 86 79 645
Yılmaz Güneş Türkiye 17 432 2.2× 122 0.8× 151 1.3× 93 1.0× 63 0.7× 84 854
Fuzai Yin China 18 180 0.9× 152 1.0× 73 0.6× 49 0.5× 53 0.6× 72 781
Bregtje A. Lemkes Netherlands 8 209 1.1× 187 1.2× 131 1.1× 168 1.8× 26 0.3× 13 942
Mustafa Altay Türkiye 15 95 0.5× 92 0.6× 125 1.0× 93 1.0× 37 0.4× 78 710
Jun Shitara Japan 16 351 1.8× 125 0.8× 206 1.7× 48 0.5× 98 1.1× 68 710
Justin T. Sambol United States 13 84 0.4× 226 1.4× 163 1.4× 55 0.6× 38 0.4× 26 664
José Carlos Arévalo‐Lorido Spain 15 306 1.6× 146 0.9× 132 1.1× 82 0.9× 79 0.9× 91 686
Eftal Murat Bakırcı Türkiye 15 247 1.3× 119 0.8× 132 1.1× 55 0.6× 146 1.7× 45 661
Miriam Shteinshnaider Israel 15 250 1.3× 104 0.7× 154 1.3× 47 0.5× 62 0.7× 36 579
Bo Shen China 17 150 0.8× 166 1.1× 244 2.0× 366 3.9× 70 0.8× 64 880

Countries citing papers authored by Xuebiao Wei

Since Specialization
Citations

This map shows the geographic impact of Xuebiao Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuebiao Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuebiao Wei more than expected).

Fields of papers citing papers by Xuebiao Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuebiao Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuebiao Wei. The network helps show where Xuebiao Wei may publish in the future.

Co-authorship network of co-authors of Xuebiao Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Xuebiao Wei. A scholar is included among the top collaborators of Xuebiao Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuebiao Wei. Xuebiao Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wei, Xuebiao, et al.. (2024). The mediating role of obesity in the development of depression in individuals with diabetes: A population-based study from NHANES 2005–2014. Journal of Affective Disorders. 351. 977–982. 14 indexed citations
3.
Wei, Xuebiao, et al.. (2024). The prognostic value of postoperative platelet levels in elderly patients after valve replacement surgery: a retrospective cohort study. BMC Cardiovascular Disorders. 24(1). 379–379. 2 indexed citations
4.
Yu, Danqing, et al.. (2024). Neohesperidin Dihydrochalcone Alleviates Lipopolysaccharide‐Induced Vascular Endothelium Dysfunction by Regulating Antioxidant Capacity. Immunity Inflammation and Disease. 12(12). e70107–e70107. 2 indexed citations
5.
Wei, Xuebiao, Yi‐Wei Xu, Yang Li, et al.. (2023). ASSESS-IE: a Novel Risk Score for Patients with Infective Endocarditis. Journal of Cardiovascular Translational Research. 17(3). 695–704. 3 indexed citations
6.
Wei, Xuebiao, et al.. (2023). Inflammatory mechanisms and intervention strategies for sepsis‐induced myocardial dysfunction. Immunity Inflammation and Disease. 11(5). e860–e860. 22 indexed citations
8.
Fu, Yanbin, et al.. (2023). Klotho alleviates contrast-induced acute kidney injury by suppressing oxidative stress, inflammation, and NF-KappaB/NLRP3-mediated pyroptosis. International Immunopharmacology. 118. 110105–110105. 47 indexed citations
9.
Wei, Xuebiao, et al.. (2023). [Research update on the molecular mechanism of MAPK signal pathway-mediated calcific aortic valve disease].. PubMed. 51(5). 542–547. 1 indexed citations
10.
Wei, Xuebiao, et al.. (2022). Escore Albumina-Bilirrubina para Predizer Desfechos em Pacientes com Cardiomiopatia Dilatada Idiopática. Arquivos Brasileiros de Cardiologia. 118(6). 1108–1115. 8 indexed citations
11.
Wang, Zhonghua, et al.. (2022). Pcv-aCO2 and procalcitonin levels for the early diagnosis of bloodstream infections caused by gram-negative bacteria. The American Journal of the Medical Sciences. 364(6). 752–757. 1 indexed citations
12.
Chen, Ziying, Lei Jiang, Pengcheng He, et al.. (2020). Zinc ameliorates human aortic valve calcification through GPR39 mediated ERK1/2 signalling pathway. Cardiovascular Research. 117(3). 820–835. 42 indexed citations
14.
Wei, Xuebiao, Weijian Chen, Chongyang Duan, et al.. (2018). Joint effects of uric acid and lymphocyte count on adverse outcomes in elderly patients with rheumatic heart disease undergoing valve replacement surgery. Journal of Thoracic and Cardiovascular Surgery. 158(2). 420–427.e1. 7 indexed citations
16.
Wei, Xuebiao, Xiaojin Chen, Xiaojin Chen, et al.. (2017). Apolipoprotein A-I: A favorable prognostic marker in infective endocarditis. Journal of clinical lipidology. 12(2). 498–505. 6 indexed citations
17.
Wei, Xuebiao, Liu Y, Pengcheng He, et al.. (2017). Combined efficacy of C-reactive protein and red blood cell distribution width in prognosis of patients with culture-negative infective endocarditis. Oncotarget. 8(41). 71173–71180. 11 indexed citations
18.
Wei, Xuebiao, Liu Y, Pengcheng He, et al.. (2016). The relationship between albuminuria and poor clinical outcomes in patients with infective endocarditis. Clinica Chimica Acta. 462. 28–32. 4 indexed citations
19.
Jiang, Lei, Pengcheng He, Yong Liu, et al.. (2015). Mechanism of IFN-γ in regulating OPN/Th17 pathway during vascular collagen remodeling of hypertension induced by ANG II.. PubMed. 8(11). 14433–40. 4 indexed citations
20.
Wei, Xuebiao, et al.. (2014). Framingham Risk Score for the prediction of coronary artery disease in patients with chronic rheumatic heart disease. Diagnosis. 1(3). 233–238. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026